Puxin Capital
VC Fund
Shanghai, China
Puxin Capital is an investment firm that targets Chinese private equity opportunities. It invests within the Chinese market in a diversified range of industries, including biotechnology, business services, construction, electronics, entertainment, financial services, food, information services, manufacturing, materials, mining, retail, software,technology, and transportation.
- Total investments:
- 10
- Last investment:
- Lead investor:
- 30%
Last updated:
For AI agents: llms.txt
Industries Puxin Capital invests in
Stages Puxin Capital invests in
Countries Puxin Capital invests in
Investment Focus
Industry
- Pharmaceutical 3 (30%)
- Information Technology 3 (30%)
- Sensor 2 (20%)
- Medical 2 (20%)
- Software 2 (20%)
Stage
- Series B 4 (40%)
- Series A 3 (30%)
- Series C 1 (10%)
- Series D 1 (10%)
- Venture - Series Unknown 1 (10%)
Country
- China 8 (80%)
- Switzerland 1 (10%)
- United States 1 (10%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Tage Zhixing
|
Beijing Tage Zhixing Technology Co., Ltd. is a high-tech enterprise focusing on mining vehicle unmanned driving technology research, product development, and overall engineering solution design and implementation of unmanned mines. Tage Zhixing has launched a car-ground-cloud collaborative smart mine unmanned transportation system, which realizescloud intelligent dispatching management, 4G. | Series D / Apr 28, 2026 | |
PaXini Tech
|
All Scenario Application—Haptic Digitization and Tactile Technology | Series A / Aug 05, 2025 | |
AlpsenTek
|
AlpsenTek is a company engaged in the research and development of machine vision sensors and algorithms. | Series B / Apr 16, 2025 | |
AI-LINK
|
AI-LINK is a digital infrastructure provider focused on industrial sites. | $21.1M / Series A / Feb 01, 2024 | |
|
Sinogen Biopharma
|
Sinogen Biopharma is founded with a vision to bridge China's biotech innovation to the US pharma market. The company licenses and develops innovative drugs from China. | Series B / Dec 30, 2023 | |
Spacetouch
|
Zhuhai Pulin Core Technology Co., Ltd. was founded by many professors and doctors of electrical engineering at Princeton University. The founding members are rich in human-computer interaction and R&D experience in the field of integrated circuits. The company is committed to human-computer interaction. The world's leading provider of corechips and solutions in the field. | Series B / Oct 13, 2022 | |
Hua Kong TsingJiao
|
Hua Kong TsingJiao is an IT company that focuses on the research, development, and construction of large-scale technology based on modern cryptography and game theory. Its computing platform implements solutions that support general computing types and is compatible with NumPy and Pytorch and other function libraries, which greatly reduces thelearning curve for users to use ciphertext calculations.The company was founded in 2018 and is based in Haidian District, Beijing, China. | $78M / Series B / Oct 13, 2021 | |
Ab&B Biotech
|
Ab&B Biotech focuses on the research and development of innovative human vaccines and multivalent vaccines. | $92.7M / Series C / Jul 16, 2021 | |
XunceTech
|
XunceTech operates a risk management system and data management service. It offers development, operation, and marketing services for private equity funds, trusts, and high-net-worth individual investors. The company's platform is based on big data and cloud computing technologies, developed a series of asset management-related products andintelligent transaction management solutions with independent intellectual property rights, enabling investors to get intelligent transactions management solutions, transaction data analysis, and transaction deep learning services. The company's platform aims to centralize data across multiple terminals and platforms used by its clients.The company was founded in 2016 and is based in Shenzhen, Guangdong, China. | $15.3M / Venture - Series Unknown / Mar 01, 2021 | |
Anda Biopharma
|
Anda Biopharma integrates high-end talents and technologies in tumor genomics, immunology, and vaccinology research, and is committed to developing new personalized therapeutic vaccines for tumors | Series A |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Puxin Capital invest in?
Puxin Capital invests primarily in Pharmaceutical, Information Technology and Sensor startups, most often at Series B and Series A stage. Most of the 10 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Puxin Capital last invest?
The most recent investment recorded for Puxin Capital closed in Apr 2026. Shizune tracks 10 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
